NeuroSense Therapeutics (NRSN) Earnings Date & Reports

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NRSN is expected to report earnings to rise 250.14% to -36 cents per share on August 27

NeuroSense Therapeutics NRSN Stock Earnings Reports

Q2'25

Est.

$-0.37

Q1'25

Beat

by $0.04

Q4'24

Missed

by $0.46

Q3'24

Beat

by $0.03

Q2'24

Beat

by $0.14

The last earnings report on May 28 showed earnings per share of -10 cents, beating the estimate of -14 cents. With 98.89K shares outstanding, the current market capitalization sits at 41.26M.

View a ticker or compare two or three

Compare

NRSN